BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stribos EG, van Werkhoven MB, Poppelaars F, van Goor H, Olinga P, van Son WJ, Damman J, Seelen MA. Renal expression of Toll-like receptor 2 and 4: Dynamics in human allograft injury and comparison to rodents. Molecular Immunology 2015;64:82-9. [DOI: 10.1016/j.molimm.2014.11.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Yang J, Snijders MLH, Haasnoot GW, van Kooten C, Mallat M, de Fijter JW, Clahsen-van Groningen MC, Claas FHJ, Eikmans M. Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome. Transpl Immunol 2018;48:39-46. [PMID: 29475090 DOI: 10.1016/j.trim.2018.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Zhang Q, Reed EF. The importance of non-HLA antibodies in transplantation. Nat Rev Nephrol 2016;12:484-95. [PMID: 27345243 DOI: 10.1038/nrneph.2016.88] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 14.2] [Reference Citation Analysis]
3 Khakpour S, Wilhelmsen K, Hellman J. Vascular endothelial cell Toll-like receptor pathways in sepsis. Innate Immun 2015;21:827-46. [DOI: 10.1177/1753425915606525] [Cited by in Crossref: 111] [Cited by in F6Publishing: 98] [Article Influence: 15.9] [Reference Citation Analysis]
4 Toldo S, Quader M, Salloum FN, Mezzaroma E, Abbate A. Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac Death. Int J Mol Sci 2016;17:E958. [PMID: 27322252 DOI: 10.3390/ijms17060958] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
5 Hosseinzadeh M, Ahmadpoor P, Yekaninejad MS, Pourrezagholi F, Foroughi F, Ghorbanpour M, Barabadi M, Shahbaz SK, Solgi G, Amirzargar A. Expression patterns of Toll like receptor (TLR)-2, TLR-4 and myeloid differentiation primary response gene 88 (MYD88) in renal transplant patients developing allograft dysfunction; a cohort study. Transpl Immunol 2018;48:26-31. [PMID: 29452169 DOI: 10.1016/j.trim.2018.02.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Radi ZA. Immunopathogenesis of Acute Kidney Injury. Toxicol Pathol 2018;46:930-43. [DOI: 10.1177/0192623318799976] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
7 Zhang Y, Peng W, Ao X, Dai H, Yuan L, Huang X, Zhou Q. TAK-242, a Toll-Like Receptor 4 Antagonist, Protects against Aldosterone-Induced Cardiac and Renal Injury. PLoS One 2015;10:e0142456. [PMID: 26556241 DOI: 10.1371/journal.pone.0142456] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
8 Di Lorenzo A, Bolli E, Tarone L, Cavallo F, Conti L. Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. Int J Mol Sci 2020;21:E9418. [PMID: 33321934 DOI: 10.3390/ijms21249418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]